Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function [NA]
This clinical trial is evaluating whether a partially hydrolyzed formula with synbiotics affects skin barrier function in individuals with a…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Comparative Analysis of Filmed Sequences for the Assessment of Discomfort in Atopic Dermatitis of Infants Under 6 Months of Age [NA]
This clinical trial update indicates that the study evaluating filmed sequences to assess discomfort in infants under 6 months with atopic d…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) [Phase 3]
Phase 3 clinical trial assessing Rocatinlimab in adolescent participants with moderate-to-severe Atopic Dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Tofacitinib for Immune Skin Conditions in Down Syndrome [Phase 2]
A Phase 2 trial evaluating tofacitinib for immune-mediated skin conditions in individuals with Down syndrome has completed, with results pos…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
This clinical trial update describes an observational retrospective cohort study in pregnant women with atopic dermatitis, comparing exposur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
Sanofi reports that the Phase 2 trial of SAR444656 in adults with moderate to severe atopic dermatitis has been terminated. The update notes…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
A clinical trial is recruiting to compare maternal, fetal, and infant outcomes in pregnant women with mild to moderate atopic dermatitis exp…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Treatment of Moderate-to-Severe Atopic Dermatitis With Ivarmacitinib in Adolescents and Adults [NA]
A clinical trial update describes testing ivarmacitinib for moderate-to-severe Atopic Dermatitis in adolescents and adults, with the study c…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis [Phase 2]
Arcutis Biotherapeutics completed a Phase 2 safety trial evaluating Roflumilast Cream 0.05% in infants aged 3 months to under 2 years with a…
-
EMA approval · 2025-12-09EMA Authorised: Anzupgo (Delgocitinib) — LEO Pharma A/S
The European Medicines Agency authorised Anzupgo (delgocitinib) by LEO Pharma A/S for dermatitis and eczema in the EU.
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants [Phase 1]
Pfizer is studying PF-08049820 in a Phase 1 trial to see if it changes how the body processes oral contraceptives, midazolam, and dabigatran…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis
Pfizer is recruiting participants for a study of Cibinqo (abrocitinib) in adults with atopic dermatitis to learn more about the study medica…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
This clinical trial update indicates that a study of the safety of Abrocitinib (CIBINQO) in pregnant women and their offspring is currently …
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating safety, tolerability, drug levels (pharmacokinetics), and dr…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
Pfizer is conducting a clinical study to evaluate abrocitinib in adults with moderate to severe atopic dermatitis, and the trial is currentl…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Moisturization and Skin Hydration Study [NA]
A University of British Columbia study evaluating moisturization and skin hydration in individuals with atopic dermatitis. The trial status …
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants [Phase 1]
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of GB-7624 in healthy adults, sponsored by Generate Biomedicines, wi…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 efficacy trial of EVO301 in moderate-to-severe atopic dermatitis has completed.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects [Phase 1]
Phase 1 bioavailability study evaluating SHR-1819 given subcutaneously in healthy subjects, comparing different injection devices to assess …
-
EMA approval · 2025-12-03EMA Authorised: Protopic (tacrolimus) — LEO Pharma A/S
The European Medicines Agency has authorised Protopic (tacrolimus) by LEO Pharma A/S for the treatment of atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]
A Phase 2 study of LY3454738 in adults with moderate-to-severe Atopic Dermatitis was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids [Phase 3]
Phase 3 trial evaluating subcutaneous amlitelimab for moderate-to-severe atopic dermatitis in participants aged 12 and older on topical cort…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis [Phase 1]
A Phase 1 multiple ascending-dose study of XmAb®27564 in psoriasis and atopic dermatitis has been terminated.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population [NA]
A pediatric trial is evaluating a milk bioactive peptide–containing emollient cream for reducing clinical signs, pruritus, and bacterial col…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
An ongoing clinical trial creating a longitudinal biorepository for multiple allergic diseases to advance research on disease mechanisms and…